Biomarkers in cardiology--part 1--in heart failure and specific cardiomyopathies - Wikidata - wikimedia - TriplyDB

Biomarkers in cardiology--part 1--in heart failure and specific cardiomyopathies

Biomarkers in cardiology--part 1--in heart failure and specific cardiomyopathies

http://www.wikidata.org/entity/Q34914470

about

Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure Cardiac Remodeling: Concepts, Clinical Impact, Pathophysiological Mechanisms and Pharmacologic Treatment.

P2860

Q28066438-C7D0584B-8F30-4DD0-9523-F9DD99270883 Q38662968-76A2B5C8-C5A7-4B37-ABD6-29523B875798

P2860

Biomarkers in cardiology--part 1--in heart failure and specific cardiomyopathies

http://www.wikidata.org/entity/Q34914470

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Biomarkers in cardiology--part 1--in heart failure and specific cardiomyopathies

@ast

Biomarkers in cardiology--part 1--in heart failure and specific cardiomyopathies

@en

Biomarkers in cardiology--part 1--in heart failure and specific cardiomyopathies

@nl

type

label

Biomarkers in cardiology--part 1--in heart failure and specific cardiomyopathies

@ast

Biomarkers in cardiology--part 1--in heart failure and specific cardiomyopathies

@en

Biomarkers in cardiology--part 1--in heart failure and specific cardiomyopathies

@nl

prefLabel

Biomarkers in cardiology--part 1--in heart failure and specific cardiomyopathies

@ast

Biomarkers in cardiology--part 1--in heart failure and specific cardiomyopathies

@en

Biomarkers in cardiology--part 1--in heart failure and specific cardiomyopathies

@nl

P1433

Q34914470-717AC0CD-F0FB-492A-96CC-5FBA421988E3

P1476

Q34914470-66511B5D-A9C0-4CC5-922D-D02834D8F01D

P2093

Q34914470-1264169B-8A45-4B75-8422-A17DC2E8E651

P275

Q34914470-1C943E52-70BC-421E-BA49-A1FD6896902B

P2860

Q34914470-039087D0-78FD-4A4C-8AE3-31C102C30FA8

Q34914470-04AE2631-9135-48B2-A08C-1E9CF0BF1470

Q34914470-14871160-E5EC-41C5-91F4-71DDFD1D549A

Q34914470-2D33B732-CCF6-44A4-A628-1D858D90760F

Q34914470-37DA3065-04F5-4701-A598-AAD3D0DE4E6F

Q34914470-4AB19222-CD6F-46E5-ACE7-0CB5B7A2FBB2

Q34914470-4B556D7A-D079-438A-9379-CF4485009799

Q34914470-4EDCE6DE-E05B-47E5-8B09-7A6B0E0F988C

Q34914470-52DDD3C2-8856-4FBF-A28F-AB40D7CE8975

Q34914470-55AB2AE6-20FB-4A12-AA64-BA5B6D8A895B

P304

Q34914470-CE62256D-2F35-45AC-BF09-2E2F95BCFDBD

P31

Q34914470-C3AAC48C-6CD1-442D-A15C-E1F1031201FF

Q34914470-CB82F006-3C34-4922-82DE-89D79406EC3E

P356

Q34914470-2EB29826-FB10-473B-998D-119B01EEA61E

P433

Q34914470-12A16DD1-DDE9-4C86-91FC-4896E96F6178

P478

Q34914470-C64D1FAD-F1FB-4B37-864E-E3367381EB19

P5008

Q34914470-DED970DD-8551-47ED-AE20-764B585BE073

P577

Q34914470-1323A7CA-0CEA-42F9-B43C-B7A7F14AE228

Q34914470-187BCEBA-94B4-428C-BFB3-2684DB111E03

P5875

Q34914470-2A4812D2-F0B8-4623-82EC-61D0F6B5F089

P698

Q34914470-0E6B3FAF-DAC1-4B3D-8332-33A15E879EF8

P921

Q34914470-769362ED-201C-42DA-8FB2-8B96D1A6875A

Q34914470-CACB0B51-CE56-4083-8D8B-28CD147C94D3

P932

Q34914470-AD8EA245-7D70-476A-8A2C-FEE91C49D303

P356

P1433

Arquivos Brasileiros De Cardiologia

P1476

Biomarkers in cardiology--part 1--in heart failure and specific cardiomyopathies

@en

P2093

EXpert Group on Biomarkers

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial 3.0 Unported

P2860

C-reactive protein: a critical update

Serum cardiac troponin I and ST-segment elevation in patients with acute pericarditis

Cardiac troponin I in acute pericarditis

Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology

Preliminary data on the potential usefulness of B-type natriuretic peptide levels in predicting outcome after hospital discharge in patients with heart failure.

Tissue doppler imaging and plasma BNP levels to assess the prognosis in patients with hypertrophic cardiomyopathy.

Cardiac involvement in systemic inflammatory diseases.

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study.

Quantifying the added value of BNP in suspected heart failure in general practice: an individual patient data meta-analysis.

Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure.

P304

451-459

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5935/ABC.20140184

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2014-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273132531

http://www.w3.org/2001/XMLSchema#string

P698

25590924

http://www.w3.org/2001/XMLSchema#string

P921

P932

4290735

http://www.w3.org/2001/XMLSchema#string